Top Tweets for #ShapeTrial
☀️ Hot takes for your summer scroll!
MIS surgery in simple hysterectomy from the subanalysis of #SHAPEtrial
🎧 In case you missed it… https://t.co/wtXNSXFwRA
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_
A very interesting episode of #IJGCconversations talking about #QoL assessment on #SHAPETrial with Sarah Ferguson
🎧 https://t.co/OmDbRHzT7f
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @thomasbartlMD @kfischermd @claritasantia @stephjeangill @MMontesinos_Alb @braunchristian1 @mattmarchettiMD @yates_elisemann @jhgelissen @pmcancercentre #cervicalcancer
#IJGCclub #QUESTION1 Do you apply #SHAPE criteria to all low-risk cases in your recent daily practice and perform simple hysterectomy, or do you still try to take more paracervical tissue even if the criteria are met?
Join us #IJGCclub
📆 15/01/2025
⏰11am CST/6pm CET
Mark your calendars 📅 for an exciting #IJGCclub 💥
Dr. Plante will discuss about the surgical approach in patients with low-risk #cervicalcancer following #simplehyst #SHAPEtrial subanalysis
📶 https://t.co/U879Rhb83X
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @thomasbartlMD @kfischermd @claritasantia @stephjeangill @MMontesinos_Alb @braunchristian1 @mattmarchettiMD @yates_elisemann @jhgelissen
The @OncoAlert 🚨Newsletter NOW OUT
Covering January 3-9, 2025
REGISTER AT https://t.co/rs8wXnwI7i OR https://t.co/hwvqbilbLO
Discussing:
✅NEWS FROM INDUSTRY: MARIPOSA Update 🦋amivantamab-vmjw plus lazertinib shows statistically significant and clinically meaningful improvement in overall survival versus osimertinib🫁 #NSCLC
✅EUROPA: Single-modality endocrine therapy💊
🆚 radiotherapy ☢️after breast-conserving surgery in women aged 70 years and older with luminal A-like early #BreastCancer by @Icro_Meattini @matteolambe
✅Negative PSMA PET ☢️can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk #ProstateCancer by @rb_incesu
@MarkusGraefen @Tilki_De
✅SHARP: Pelvic regional control with 25Gy☢️ in 5 fractions in SBRT for high risk prostate #cancer by @VedangMurthy @TataMemorial @ACTREC_TMC
@docpriyamvada @indranilsays @docpriyamvada
@MSteinbergMD @DrAndrewLoblaw @AmarUKishan
✅The effect of tumor downsizing on surgical complexity during nephrectomy after immune checkpoint inhibitors for metastatic renal cell carcinoma #KidneyCancer by @PignotG @AlbigesL @laconss
✅TROPION-Lung05: Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell #LungCancer With Actionable Genomic Alterations🧬 @sands_jacob @LuisPaz_Ares
✅Immunotherapy for advanced-stage squamous cell lung cancer🫁: the state of the art and outstanding questions by @peters_solange
✅SHAPE: Minimally invasive compared to open surgery in patients with low-risk #CervicalCancer following simple hysterectomy out on @IJGConline @ESGO_society
✅Feasibility of a cancer screening program using multicancer early detection testing and whole-body magnetic resonance imaging in a high-risk population out on @JournalCancer
#OncoAlertAF
@nataliagandur @acampsmalea @BiagioRicciutMD
@yekeduz_emre @HHorinouchi @FadiHaddad_MD
@Dr_Ivanoncologo @Abdallah81MD @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK
@gusviani @acmoorephd @UmbertoMalapel1 @DrFMartinelli @RManochakian @scserendipity1 @PGrivasMDPhD
#LeadArticle MIS or open surgery in patients with low-risk #cervicalcancer #SHAPEtrial subanalysis
🔍 https://t.co/ihlwNKGkER
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @thomasbartlMD @kfischermd @claritasantia @stephjeangill @MMontesinos_Alb @braunchristian1 @mattmarchettiMD
And what a way to start the year! 🎉
In the first #IJGCconversations episode 🎙️, Dr. Marie Plante dives into the role of #MIS in Simple Hysterectomy: #SHAPEtrial subanalysis.
Don't miss it! 🎧 https://t.co/roODZrlgkR
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
@thomasbartlMD @kfischermd @claritasantia @stephjeangill @MMontesinos_Alb @braunchristian1 @mattmarchettiMD
@RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada
Dr Marie Plante discusses the safety of #MIS in patients in #SHAPE trial
@pedroramirezMD @IGCSociety @IJGConline @OncoAlert @GynMe4 @IJGCfellows
#IGCS2024 #GynecologicCancer #UterineCancer #Some4GynOnc
💥The #SHAPEtrial has been published!
Listen again this episode with Dr. Plante
🎙️ https://t.co/RnT0qSDsij
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
💥When Less Is More — The Importance of Patient Selection #SHAPEtrial 💥
The editorial made by our EIC @pedroramirezMD
@HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @RParejaGineOnco @IJGCfellows
In the SHAPE randomized trial in patients with low-risk cervical cancer, simple hysterectomy was not inferior to radical hysterectomy with respect to 3-year pelvic recurrence & was associated with a lower risk of urologic complications. Full trial results: https://t.co/VyTlheyJlG
Excited about the #SHAPEtrial results?
@pedroramirezMD talked w/ Dr. Plante about the safety of a #SimpleHyst in low-risk #CervicalCancer 🤩
🎙️ https://t.co/MuxO1FFSJX
@HsuMd @JayrajAarthi @AndreFernandes2 @agz_eriksson @IGCSociety @ESGO_society @OncoAlert @IJGCfellows @GynMe4
Major practice change results that will impact #cervicalcancer #SHAPEtrial 🙌👏 Congratulations to Dr Plante and collaborators!
#SHAPE trial
🌟simple hysterectomy for early stage #cervicalcancer
🌟simple vs radical hyst 1A2-1B1 (<2cm) confirms non-inferiority of a 3yr pelvic recurrence rate and secondary endpts PFS/OS are met
@OncoAlert @GynMe4 @IJGConline
#SHAPETrial #ASCO2023
SH vs RH in Low-risk early-stage CC
75% MIS (50% laparoscopic; 25% robotic)
25% Open
- No ≠ in pelvic rec rate and OS
- ↑QoL and ↓complications in SH
#GynOnco
@SGO_org @IGCSociety @ESGO_society @OncoAlert @Gyne_Oncology
https://t.co/RIlsAw9cL6
🌟The #SHAPEtrial will provide more concrete data on the role of simple hysterectomy for early-stage cervical cancer.
@BatistaTP @oncohoegl @DrFHidalgo @RParejaGineOnco @gefcintra @audreytsunoda
Last Seen Hashtags on Sotwe
irl
Seen from United Kingdom
incineroarday
Seen from United Kingdom
BoycottKamalHassan
Seen from Korea
oilporn
Seen from Malaysia
BreastCsncerSurvivor
Seen from United States
momson() + filter:native_video
Seen from Russia
Amateur
Seen from Turkey
mallucouple
Seen from India
韓国旅行準備
Seen from Vietnam
คลิปดัง
Seen from Thailand
Most Popular Users
Elon Musk 
@elonmusk
241.1M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.2M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.4M followers
KATY PERRY
@katyperry
88.8M followers
Taylor Swift
@taylorswift13
82.7M followers
Lady Gaga
@ladygaga
74.2M followers
Virat Kohli
@imvkohli
71.6M followers
Kim Kardashian
@kimkardashian
70.3M followers
YouTube
@youtube
68.7M followers
Neymar Jr
@neymarjr
64.5M followers
Bill Gates
@billgates
64.5M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
61.9M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers